• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exceptional Response to Cabozantinib of Rapidly Evolving Brain Metastases of Renal Cell Carcinoma: A Case Report and Review of the Literature.

作者信息

Ciccarese Chiara, Iacovelli Roberto, Mosillo Claudia, Tortora Giampaolo

机构信息

Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.

Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.

出版信息

Clin Genitourin Cancer. 2018 Oct;16(5):e1069-e1071. doi: 10.1016/j.clgc.2018.06.005. Epub 2018 Jun 21.

DOI:10.1016/j.clgc.2018.06.005
PMID:30005936
Abstract
摘要

相似文献

1
Exceptional Response to Cabozantinib of Rapidly Evolving Brain Metastases of Renal Cell Carcinoma: A Case Report and Review of the Literature.卡博替尼对快速进展的肾细胞癌脑转移的显著疗效：一例报告并文献复习
Clin Genitourin Cancer. 2018 Oct;16(5):e1069-e1071. doi: 10.1016/j.clgc.2018.06.005. Epub 2018 Jun 21.
2
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.卡博替尼在肾细胞癌放射性耐药脑转移瘤中的活性：两例报告
J Med Case Rep. 2018 Nov 25;12(1):351. doi: 10.1186/s13256-018-1875-9.
3
In brief: Cabozantinib (Cabometyx) for advanced renal cell carcinoma.简而言之：卡博替尼（Cabometyx）用于晚期肾细胞癌。
Med Lett Drugs Ther. 2016 Jul 18;58(1499):e97.
4
Cabozantinib improves clinical outcomes in renal cancer.卡博替尼可改善肾癌的临床疗效。
Lancet Oncol. 2017 Jan;18(1):e2. doi: 10.1016/S1470-2045(16)30620-9. Epub 2016 Nov 25.
5
Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis.既往酪氨酸激酶抑制剂对接受纳武单抗或卡博替尼治疗的转移性肾细胞癌患者生存的影响：基于文献的荟萃分析数据
Eur Urol. 2017 Dec;72(6):1027-1028. doi: 10.1016/j.eururo.2017.07.019. Epub 2017 Jul 29.
6
Cabozantinib use in renal cell carcinoma.卡博替尼在肾细胞癌中的应用。
Drugs Today (Barc). 2017 May;53(5):299-307. doi: 10.1358/dot.2017.53.5.2623107.
7
Cabozantinib in renal cell carcinoma: only a METEOR or a rising star?卡博替尼治疗肾细胞癌：只是一颗流星还是一颗冉冉升起的新星？
Acta Biomed. 2016 Sep 13;87(2):224-5.
8
Cabozantinib: A Review in Advanced Renal Cell Carcinoma.卡博替尼：晚期肾细胞癌的研究进展。
Drugs. 2016 Dec;76(18):1771-1778. doi: 10.1007/s40265-016-0661-5.
9
Symptomatic treatment of brain metastases in renal cell carcinoma with sorafenib.索拉非尼对肾细胞癌脑转移的对症治疗。
J Cancer Res Ther. 2018 Dec;14(Supplement):S1223-S1226. doi: 10.4103/0973-1482.189402.
10
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer.卡博替尼在骨转移性肾细胞癌和去势抵抗性前列腺癌中的生物学问题。
Future Oncol. 2018 Oct;14(25):2559-2564. doi: 10.2217/fon-2018-0158. Epub 2018 Aug 24.

引用本文的文献

1
An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases.肾细胞癌全身靶向治疗概述，重点关注转移性肾细胞癌和脑转移
Curr Issues Mol Biol. 2023 Sep 21;45(9):7680-7704. doi: 10.3390/cimb45090485.
2
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor.发现并优化首个 ATP 竞争型 III 型 c-MET 抑制剂。
J Med Chem. 2023 Jul 13;66(13):8782-8807. doi: 10.1021/acs.jmedchem.3c00401. Epub 2023 Jun 21.
3
RET signaling pathway and RET inhibitors in human cancer.
人类癌症中的RET信号通路与RET抑制剂
Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022.
4
Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma.卡博替尼治疗肾细胞癌脑转移的疗效。
IJU Case Rep. 2022 May 3;5(4):293-296. doi: 10.1002/iju5.12459. eCollection 2022 Jul.
5
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.TRK xDFG 突变触发从 I 型到 II 型激酶抑制剂的敏感性开关。
Cancer Discov. 2021 Jan;11(1):126-141. doi: 10.1158/2159-8290.CD-20-0571. Epub 2020 Oct 1.
6
No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases.对于转移性肾细胞癌和脑转移患者，检查点抑制剂单药治疗未引起范式改变。
Ann Transl Med. 2019 Nov;7(22):612. doi: 10.21037/atm.2019.11.50.
7
Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma.转移性肾细胞癌患者在放疗前对卡博替尼的脑部完全缓解。
Case Rep Urol. 2019 Feb 13;2019:6769017. doi: 10.1155/2019/6769017. eCollection 2019.
8
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.卡博替尼在肾细胞癌放射性耐药脑转移瘤中的活性：两例报告
J Med Case Rep. 2018 Nov 25;12(1):351. doi: 10.1186/s13256-018-1875-9.
9
Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma.卡博替尼用于转移性透明细胞肾细胞癌的治疗
J Kidney Cancer VHL. 2018 Oct 8;5(4):1-5. doi: 10.15586/jkcvhl.2018.109. eCollection 2018.